BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25450399)

  • 1. Interaction between S100P and the anti-allergy drug cromolyn.
    Penumutchu SR; Chou RH; Yu C
    Biochem Biophys Res Commun; 2014 Nov; 454(3):404-9. PubMed ID: 25450399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy.
    Arumugam T; Ramachandran V; Sun D; Peng Z; Pal A; Maxwell DS; Bornmann WG; Logsdon CD
    Mol Cancer Ther; 2013 May; 12(5):654-62. PubMed ID: 23303403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
    Arumugam T; Ramachandran V; Logsdon CD
    J Natl Cancer Inst; 2006 Dec; 98(24):1806-18. PubMed ID: 17179482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
    Penumutchu SR; Chou RH; Yu C
    PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-Bound S100P Protein Is a Promiscuous Binding Partner of the Four-Helical Cytokines.
    Kazakov AS; Deryusheva EI; Permyakova ME; Sokolov AS; Rastrygina VA; Uversky VN; Permyakov EA; Permyakov SE
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
    Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
    Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE).
    Arumugam T; Simeone DM; Schmidt AM; Logsdon CD
    J Biol Chem; 2004 Feb; 279(7):5059-65. PubMed ID: 14617629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
    Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
    J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100P, a peculiar member of S100 family of calcium-binding proteins implicated in cancer.
    Tóthová V; Gibadulinová A
    Acta Virol; 2013; 57(2):238-46. PubMed ID: 23600880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium-dependent interaction of monomeric S100P protein with serum albumin.
    Kazakov AS; Shevelyova MP; Ismailov RG; Permyakova ME; Litus EA; Permyakov EA; Permyakov SE
    Int J Biol Macromol; 2018 Mar; 108():143-148. PubMed ID: 29175526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100P promotes pancreatic cancer growth, survival, and invasion.
    Arumugam T; Simeone DM; Van Golen K; Logsdon CD
    Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.
    Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA
    FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100P Interacts with p53 while Pentamidine Inhibits This Interaction.
    Katte RH; Dowarha D; Chou RH; Yu C
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33923162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
    Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
    Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization and divalent ion binding properties of the S100P protein: a Ca2+/Mg2+-switch model.
    Gribenko AV; Makhatadze GI
    J Mol Biol; 1998 Oct; 283(3):679-94. PubMed ID: 9784376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100P: a novel therapeutic target for cancer.
    Arumugam T; Logsdon CD
    Amino Acids; 2011 Oct; 41(4):893-9. PubMed ID: 20509035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
    Chiou JW; Fu B; Chou RH; Yu C
    PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.
    Onyeagucha BC; Mercado-Pimentel ME; Hutchison J; Flemington EK; Nelson MA
    Exp Cell Res; 2013 Aug; 319(13):2081-2090. PubMed ID: 23693020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monomeric state of S100P protein: Experimental and molecular dynamics study.
    Permyakov SE; Denesyuk AI; Denessiouk KA; Permyakova ME; Kazakov AS; Ismailov RG; Rastrygina VA; Sokolov AS; Permyakov EA
    Cell Calcium; 2019 Jun; 80():152-159. PubMed ID: 31103949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational and thermodynamic properties of peptide binding to the human S100P protein.
    Gribenko AV; Guzmán-Casado M; Lopez MM; Makhatadze GI
    Protein Sci; 2002 Jun; 11(6):1367-75. PubMed ID: 12021435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.